The objective of the current study is to show that the immune response of subjects previously vaccinated with one or two doses of IMVAMUNE® can be boosted two years later with one IMVAMUNE® vaccination. Assessment of individual antibody titers within short time intervals following the booster vaccination will provide information on how fast and effective measurable antibody titers can be reactivated.